Anova Biomedical
PrivateLast Round
Grant
Sep 17, 2025
Total Funding Raised
$968,200
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Anova Biomedical is a biotechnology company that develops synthetic, bioresorbable vascular grafts designed to improve long-term outcomes for hemodialysis and cardiovascular patients.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Anova Biomedical Comparables
Compare Anova Biomedical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vascudyne | 87% | |
| Healionics Corporation | 85% | |
| Angio-Graft LLC | 83% |
Anova Biomedical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 17, 2025 | ||||
| Grant | Jul 1, 2025 | ||||
| Grant | Oct 1, 2024 | ||||
| Grant | Sep 1, 2024 | ||||
| Grant | Jul 1, 2024 |
Key People
Founding team and executive leadership
Anova Biomedical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Center for Technology Licensing at Cornell University | Accelerator |
| FuzeHub | Grant |
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
| Empire State Development's Division of Science, Technology and Innovation (NYSTAR) | Grant |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 17, 2025
Received grant from Empire State Development's NYSTAR.
- Jul 1, 2025
$298K grant from National Institute of Diabetes and Digestive and Kidney Diseases.
Anova Biomedical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Anova Biomedical's valuation, stock price, and market status.
Is Anova Biomedical a public or private company?
Anova Biomedical is a private company.
What is the current stock price of Anova Biomedical?
Anova Biomedical is a private company with no public stock price. No recent secondary market data is available.
How much is Anova Biomedical worth (valuation)?
Valuation information for Anova Biomedical is not publicly available.
Can I buy Anova Biomedical stock?
Anova Biomedical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Anova Biomedical's last funding round?
Anova Biomedical's most recent funding round was Grant on September 17, 2025.
Who are the main investors in Anova Biomedical?
Key investors in Anova Biomedical include Center for Technology Licensing at Cornell University, FuzeHub, National Institute of Diabetes and Digestive and Kidney Diseases, Empire State Development's Division of Science, Technology and Innovation (NYSTAR), National Science Foundation.
Will Anova Biomedical IPO soon?
No public IPO plans have been announced for Anova Biomedical.
How can I track Anova Biomedical secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Anova Biomedical's secondary market activity and sign up for updates.